Byong Duk Ye

Research interests

Publications

• Randomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease

  Gastroenterology · 2021 · https://doi.org/10.1053/j.gastro.2021.02.068

• Endoscopic diagnosis and treatment planning for colorectal polyps using a deep-learning model

  Scientific Reports · 2020 · 10.1038/s41598-019-56697-0

• A 30-year Trend Analysis in the Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District of Seoul, Korea in 1986–2015

  Journal of Crohn s and Colitis · 2019 · https://doi.org/10.1093/ecco-jcc/jjz081

• Best practices on immunomodulators and biologic agents for ulcerative colitis and Crohn’s disease in Asia

  Intestinal Research · 2019 · 10.5217/ir.2019.00026

• Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

  The Lancet · 2019 · https://doi.org/10.1016/s0140-6736(18)32196-2

• MR Enterography for the Evaluation of Small-Bowel Inflammation in Crohn Disease by Using Diffusion-weighted Imaging without Intravenous Contrast Material: A Prospective Noninferiority Study

  Radiology · 2015 · 10.1148/radiol.2015150809

• A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia

  Nature Genetics · 2014 · https://doi.org/10.1038/ng.3060

• Genome-wide association study of Crohn's disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations

  Gut · 2013 · https://doi.org/10.1136/gutjnl-2013-305193

• Endoscopic submucosal dissection for treatment of rectal carcinoid tumors

  Gastrointestinal Endoscopy · 2010 · 10.1016/j.gie.2010.01.040

• Development, validation, and responsiveness of a novel disease activity index for intestinal Behcetʼs disease

  Inflammatory Bowel Diseases · 2010 · 10.1002/ibd.21313

• Development and Validation of Novel Diagnostic Criteria for Intestinal Behçet's Disease in Korean Patients With Ileocolonic Ulcers

  The American Journal of Gastroenterology · 2009 · 10.1038/ajg.2009.331

• Comparison of 7‐day and 14‐day Proton Pump Inhibitor‐Containing Triple Therapy for Helicobacter pylori Eradication: Neither Treatment Duration Provides Acceptable Eradication Rate in Korea

  Helicobacter · 2007 · 10.1111/j.1523-5378.2007.00468.x

Current projects

No projects listed.